Cargando…
Spectrum of Mucormycosis Before and During COVID-19: Epidemiology, Diagnosis, and Current Therapeutic Interventions
PURPOSE OF REVIEW: More than half a billion people have been infected and 6.2 million killed by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) since the start of the pandemic in 2019. Systemic glucocorticoids are a double-edged sword, on the one hand, life-saving in treating C...
Autores principales: | Mansoor, Sheikh, Ahmed, Tousief Irshad, Happa, Karan, Sultan, Mehnaz, Manhas, Sweeta, Shamas, Suhaib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364274/ https://www.ncbi.nlm.nih.gov/pubmed/35967987 http://dx.doi.org/10.1007/s12281-022-00438-w |
Ejemplares similares
-
Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis
por: Ostovan, Vahid Reza, et al.
Publicado: (2022) -
Overview of COVID-19-Associated Invasive Fungal Infection
por: Shishido, Akira A., et al.
Publicado: (2022) -
Prevalence of Fungal Drug Resistance in COVID-19 Infection: a Global Meta-analysis
por: Habibzadeh, Adrina, et al.
Publicado: (2022) -
COVID-19 and Plethora of Fungal Infections
por: Kundu, Reetu, et al.
Publicado: (2022) -
Inactivated vaccine Covaxin/BBV152: A systematic review
por: Ahmed, Tousief Irshad, et al.
Publicado: (2022)